Related Experiment Video
Updated: Mar 20, 2026

07:07
Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy
Published on: August 3, 2021
3.2K
Atypical Manifestations in Glut1 Deficiency Syndrome.
V De Giorgis1, C Varesio2, C Baldassari2
1Brain and Behaviour Department, University of Pavia, Pavia, Italy.
Journal of Child Neurology
|June 3, 2016
Summary
Glucose transporter type 1 deficiency syndrome (GlcD1) is a neurological disorder caused by SCL2A1 gene mutations, leading to impaired brain glucose transport. This review details less common GlcD1 symptoms to aid diagnosis.
Area of Science:
- Neurology
- Genetics
- Metabolic Disorders
Background:
- Glucose transporter type 1 deficiency syndrome (GlcD1) is a rare, inherited neurological disorder.
- It stems from mutations in the SLC2A1 gene, impairing glucose transport to the brain.
- The condition presents with a diverse range of symptoms, often including cognitive deficits and movement disorders.
Purpose of the Study:
- To review the broad clinical spectrum of GlcD1.
- To highlight and describe less commonly reported, peculiar clinical manifestations.
- To provide resources for accurate and timely diagnosis of GlcD1.
Main Methods:
- Literature review focusing on GlcD1.
- Analysis of clinical presentations, including rare symptoms.
- Inclusion of video evidence for specific manifestations.
Main Results:
- GlcD1 typically presents with cognitive impairment, epilepsy, dyskinesia, microcephaly, anemia, and gait issues.
- Oculogyric crises, weakness, and various forms of paroxysmal dyskinesia are peculiar but under-described symptoms.
- These diverse symptoms can present in various combinations.
Conclusions:
- GlcD1 exhibits a wide and sometimes unusual clinical spectrum.
- Recognizing less common manifestations like oculogyric crises and specific dyskinesias is crucial.
- Enhanced understanding aids in achieving a correct and rapid diagnosis of GlcD1.
Related Concept Videos
Glucose Transporters
28.0K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.0K
Inborn Errors of Metabolism
995
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
995
Chronic Kidney Disease II: Clinical Manifestations
897
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
897
Antiepileptic Drugs: Glutamate Antagonists
1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Disorders of the Skeletal Muscle
2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Myasthenia Gravis: Overview and Treatment
3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K

